https://www.curateqbio.com/news/ 2026-05-05T13:02:34+00:00 https://www.curateqbio.com/press-release/aurobindo-arm-curateq-reports-positive-phase-3-results-for-allergy-drug-bp11/ 2026-05-05T06:51:28+00:00 https://static.curateqbio.com/wp-content/uploads/2026/04/curateq-feature-scaled-1.webp https://www.curateqbio.com/press-release/aurobindo-pharma-targets-2029-as-turning-point-for-its-biosimilars-business/ 2026-05-05T12:35:45+00:00 https://static.curateqbio.com/wp-content/uploads/2026/02/aurobindo-news-scaled-1.webp https://www.curateqbio.com/press-release/curateq-biologics-announces-positive-phase-3-results-for-denosumab-biosimilar/ 2026-05-05T12:37:20+00:00 https://static.curateqbio.com/wp-content/uploads/2023/01/shutterstock_1971115256.png https://www.curateqbio.com/press-release/curateq-biologics-receives-ec-marketing-authorization-for-trastuzumab-biosimilar-dazublys/ 2026-05-05T12:39:11+00:00 https://static.curateqbio.com/wp-content/uploads/2024/01/infrastructure-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-receives-chmp-positive-opinion-for-dazublys-trastuzumab-biosimilar/ 2026-05-05T12:40:42+00:00 https://static.curateqbio.com/wp-content/uploads/2023/04/Screenshot-2022-11-15-at-15.02.06.jpg https://www.curateqbio.com/press-release/curateq-biologics-completes-phase-1-study-for-denosumab-biosimilar/ 2026-05-05T12:42:16+00:00 https://static.curateqbio.com/wp-content/uploads/2022/01/3962487-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-receives-chmp-positive-opinion-for-pegfilgrastim-biosimilar/ 2026-05-05T12:43:48+00:00 https://static.curateqbio.com/wp-content/uploads/2022/01/blank-white-label-injection-bottle-glass-vial-with-syringe-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-receives-uk-mhra-approval-for-bevqolva-bevacizumab-biosimilar/ 2026-05-05T12:45:34+00:00 https://static.curateqbio.com/wp-content/uploads/2022/01/3956381-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-receives-chmp-positive-opinion-for-filgrastim-biosimilar/ 2026-05-05T12:47:45+00:00 https://static.curateqbio.com/wp-content/uploads/2022/01/blank-white-label-injection-bottle-glass-vial-with-syringe-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-receives-ema-gmp-certificate/ 2026-05-05T12:49:34+00:00 https://static.curateqbio.com/wp-content/uploads/2024/01/infrastructure-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-successfully-completes-phase-1-trial-for-omalizumab-biosimilar/ 2026-05-05T12:52:03+00:00 https://static.curateqbio.com/wp-content/uploads/2022/01/3966736-scaled.jpg https://www.curateqbio.com/press-release/auro-peptides-completes-us-fda-inspection-with-zero-observations/ 2026-05-05T12:53:28+00:00 https://static.curateqbio.com/wp-content/uploads/2024/02/Auro-Peptides.jpg https://www.curateqbio.com/press-release/curateq-biologics-trastuzumab-biosimilar-receives-recommendation-for-marketing-authorization-in-india/ 2026-05-05T12:54:55+00:00 https://static.curateqbio.com/wp-content/uploads/2024/01/infrastructure-scaled.jpg https://www.curateqbio.com/press-release/curateq-biologics-enters-into-global-biologics-cdmo-space/ 2026-05-05T12:56:51+00:00 https://static.curateqbio.com/wp-content/uploads/2023/02/header-biosimilar-manufacturing.png https://www.curateqbio.com/press-release/curateq-biologics-onboards-ustekinumab-biosimilar/ 2026-05-05T12:58:30+00:00 https://static.curateqbio.com/wp-content/uploads/2023/09/ustekinumab_biosimilar.png https://www.curateqbio.com/press-release/curateq-biologics-announces-positive-phase-3-results-for-trastuzumab-biosimilar/ 2026-05-05T13:00:02+00:00 https://static.curateqbio.com/wp-content/uploads/2023/09/positive_phase-3.png https://www.curateqbio.com/press-release/aurobindo-pharma-arm-curateq-expands-scope-of-biosimilars-distribution-pact-with-orion/ 2026-05-05T13:01:18+00:00 https://static.curateqbio.com/wp-content/uploads/2023/09/aurobindo_pharma_news.png https://www.curateqbio.com/press-release/aurobindo-pharma-forays-into-biosimilars-development-through-an-acquisition-of-four-products-from-tl-biopharmaceutical-ag/ 2026-05-05T13:02:34+00:00 https://static.curateqbio.com/wp-content/uploads/2023/03/contact-building-shot.jpg